Replies to post #130968 on Biotech Values

[DewDiligence]

A year ago I would’ve been keenly interested in these Angiomax results insofar as they could have affected the prospects for MNTA’s M118. However, I no longer ascribe any value whatsoever to the M118 program. Regards, Dew